Infliximab as effective treatment for aseptic neutrophilic myositis

Neurology. 2019 Dec 3;93(23):1009-1011. doi: 10.1212/WNL.0000000000008584. Epub 2019 Oct 29.

¹ From the Sorbonne Université (P.G.-J., O.B., Y.A.), INSERM UMRS_974, Center of Research in Myology, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital; Université Paris Descartes (S.G.), Service de Dermatologie, Hôpital Cochin-Centre Tarnier, APHP; Department of Neurology and Myology (S.L.-L.), Pitié-Salpêtrière Hospital; and Department of Dermatology (S.B.), Pitié-Salpêtrière Hospital, Paris, France. [email protected].
² From the Sorbonne Université (P.G.-J., O.B., Y.A.), INSERM UMRS_974, Center of Research in Myology, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Pitié-Salpêtrière Hospital; Université Paris Descartes (S.G.), Service de Dermatologie, Hôpital Cochin-Centre Tarnier, APHP; Department of Neurology and Myology (S.L.-L.), Pitié-Salpêtrière Hospital; and Department of Dermatology (S.B.), Pitié-Salpêtrière Hospital, Paris, France.

No abstract available

Publication types